Predict your next investment

HEALTHCARE | Drug Development
Covalys Biosciences

See what CB Insights has to offer

Founded Year

2002

Stage

Series B | Alive

Total Raised

$4.79M

About Covalys

Developer of molecular protein research tools. The company develops and provides technology designed to enable the attachment of a broad range of chemical substances to recombinant proteins of interest. Products have particular application in protein labeling, immobilization, and purification.

Covalys Headquarter Location

Benkenstrasse 254

Witterswil, 4108,

Switzerland

41 61 725 20 50

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.